Nov 19, 2021

PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing Patent Applications

PsyBio Therapeutics Furthers Intellectual Property Portfolio with Six New Manufacturing P...

Nov 1, 2021

Psybio Announces Filing of Final Base Shelf Prospectus

Psybio Announces Filing of Final Base Shelf Prospectus Canada NewsWire ...

Oct 25, 2021

PsyBio Therapeutics CEO, Evan Levine, to Participate in Panel Discussion at the MedTech Innovation Conference on October 29th

PsyBio Therapeutics CEO, Evan Levine, to Participate in Panel Discussion at the MedTech I...

Oct 21, 2021

PsyBio Therapeutics Announces Electronic Clearing and Settlement by Depository Trust Company

PsyBio Therapeutics Announces Electronic Clearing and Settlement by Depository Trust Comp...

Oct 18, 2021

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewing

KCSA Psychedelics Virtual Investor Conference Presentations Available for On-Demand Viewi...

Oct 11, 2021

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14th

KCSA Psychedelics Virtual Investor Conference Agenda Announced for October 13th & 14t...

Oct 11, 2021

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on October 14th

PsyBio Therapeutics to Present at the KCSA Psychedelics Virtual Investor Conference on Oc...

Oct 7, 2021

PsyBio Therapeutics Successfully Demonstrates Commercial Scale Manufacturing Feasibility

PsyBio Therapeutics Successfully Demonstrates Commercial Scale Manufacturing Feasibility ...

Sep 23, 2021

PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted to the United States Food and Drug Administration

PsyBio Therapeutics Announces Pre-IND Application Request Has Been Submitted to the Unite...

Sep 20, 2021

PsyBio Therapeutics Announces Participation in Upcoming Investor Conferences in September 2021

PsyBio Therapeutics Announces Participation in Upcoming Investor Conferences in September...